169170 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types Neurological cells
METHOD FOR SCREENING REFRESHING ESSENTIAL OILS OR PRODUCTS THEREOF
#302Three dimensional heterogeneously differentiated tissue culture
#303METHODS FOR DRUG DISCOVERY USING STEM CELL-DERIVED SCHWANN CELLS
#304Material for screening for compound acting on ION channel and use thereof
#305MEANS AND METHODS FOR TREATING PARKINSON'S DISEASE
#306Biosensor exhibiting sensitivity to trinitrotoluene
#307A NON-HUMAN ANIMAL MODEL OF NEURODEGENERATIVE DISORDERS
#308Method of Identifying Transmembrane Protein-interacting Compounds
#309Oligonucleotides for inducing paternal UBE3A expression
#310Somatic opsins for single cell resolution optogenetics
#311Messenger RNA based expression of opsins and reporter proteins for electrophysiologic characterization of in vitro neurons and cardiomyocytes
#312Reducing abnormal accumulation of TDP-43 in motor neurons in amyotrophic lateral sclerosis and/or frontotemporal dementia using a construct encoding cyclin F
#313Agents directed against a cis RGMa/neogenin interaction or lipid rafts and use of the same in methods of treatment
#314STEM CELL-DERIVED SCHWANN CELLS
#315NON-HUMAN ANIMAL EXHIBITING DIMINISHED UPPER AND LOWER MOTOR NEURON FUNCTION AND SENSORY PERCEPTION
#316BIOLOGICALLY RELEVANT IN VITRO SCREENING OF HUMAN NEURONS
#317Neuronal and Oligodendrocyte Survival Modulation
#318Neuronal axon mimetics for in vitro analysis of neurological diseases, myelination, and drug screening
#319LIGHT-ACTIVATED CHIMERIC OPSINS AND METHODS OF USING THE SAME
#320Assay for diagnosing Alzheimer's disease
#321Adeno-associated virus virions with variant capsid
#322METHOD FOR MODULATING MYELINATION
#323Schwann cell differentiation promoting agent and a peripheral nerve regeneration promoting agent
#324Treatment of Neurodegeneration and Neuroinflammation
#325Method for obtaining microglia from pluripotent stem cells
#326MICROELECTRONIC HUMAN BLOOD BRAIN BARRIER
#327Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNS
#328Recombinant polynucleotide coding for polypeptide comprising reporter moiety, substrate moiety and destabilizing moiety, host cell comprising same and use of same
#329Device and method for concomitant ejection and suction of perfusate
#330METHODS FOR DETERMINING THE EFFICACY PROFILE OF A DRUG CANDIDATE
#331Benzimidazole-carboxamide compounds as 5-HTreceptor agonists
#332Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#333TREATING OPTIC NEURITIS WITH INDUCED PLURIPOTENT STEM CELL-DERIVED OLIGODENDROCYTE PRECURSOR CELLS
#334REGULATORS OF ANAPLASTIC LYMPHOMA KINASE AND USES THEREOF
#335PEPTIDE FOR INHIBITING BINDING OF AMYLOSPHEROIDS (ASPD), AND EVALUATION AND SCREENING METHOD
#336Compositions and methods for modulating neuronal excitability and motor behavior
#337In vitro model for blood-brain barrier and method for producing in vitro model for blood-brain barrier
#338HIGH THROUGHPUT SCREENING OF AGENTS ON DOPAMINERGIC NEURONS
#339TREATMENT AND PREVENTION OF STROKE AND OTHER NEUROLOGICAL DISORDERS
#340Methods to treat neurodegenerative diseases
#341Neurodegenerative disorders
#342DEVICES, COMPOSITIONS AND RELATED METHODS FOR DIAGNOSING AUTISM
#343Derivation of human microglia from pluripotent stem cells
#344In vitro assays for inhibition of microglial activation
#345Brain derived PPARα ligands
#346Cellular test systems for the determination of the biological activities of neurotoxin polypeptides
#347Diagnostic methods for neural disorders
#348Reprogramming-based models of neurodevelopmental disorders and uses thereof
#349High throughput optical assay of human mixed cell population spheroids
#350Supported in vitro developed tissue culture and culturing methods
#351Methods of using graphene and graphene-related materials for manipulation of cell membrane potential
#352Expansion and differentiation of inner ear supporting cells and methods of use thereof
#353FLT3 receptor antagonists for the treatment or the prevention of pain disorders
#354Method and composition for generating basal forebrain cholinergic neurons (BFCNS)
#355SOLUBLE HIGH MOLECULAR WEIGHT (HMW) TAU SPECIES AND APPLICATIONS THEREOF
#356Method for determining decrease in functions of hippocampus by using correlation between micro RNA and NMDA receptor, method for inhibiting decrease in functions, and method for screening for inhibitors of decrease in functions
#357Treatment of tinnitus through modulation of chloride co-transporter NKCC1 in the auditory system
#358Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#359Multiwell cell culture system having rotating shafts for mixing culture media and method of use thereof
#360Treatment of neurological and neurodevelopmental diseases and disorders associated with aberrant ion channel expression and activity
#361Engineered 3D-printed artificial axons
#362MODULATION OF AXON DEGENERATION
#363Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#364Methods and devices for live cell imaging analysis
#365Method of identifying novel protein aggregation inhibitors based on chemical kinetics
#366Method for the identification of sensory neuron subtypes in ex vivo preparations
#367ASTROCYTE DIFFERENTIATION PROTOCOL
#368Kit and method for producing induced embryonic neural progenitors
#369NON-INVASIVE, IN VITRO FUNCTIONAL TISSUE ASSAY SYSTEMS
#370Personalized 3D neural culture system for generating human oligodendrocytes and studying myelination in vitro
#371Means and methods for generating midbrain organoids
#372METHOD OF NOCICEPTOR DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS AND USES THEREOF
#373Systems and methods for assessing data collected from an electrically active cell culture
#374Method for measuring immunostimulatory response of immune cell, method for determining ability to form immune synapse in immune cell, and cell analyzer
#375Method for generating Retinal Pigment Epithelium (RPE) cells from Induced Pluripotent Stem Cells (IPSCs)
#376ETS factors regulate neural stem cell depletion and gliogenesis in Ras pathway glioma
#377Method for identifying a compound useful in mitigating and/or the treatment of a disease associated with abnormal astrocytic function
#378Synthetic blood vessels and uses thereof
#379Method of Identifying Transmembrane Protein-interacting Compounds
#380METHOD AND MEDIUM FOR NEURAL DIFFERENTIATION OF PLURIPOTENT CELLS
#381METHOD FOR PRODUCING RETINAL TISSUE
#382Fluorogenic pH sensitive dyes and their method of use
#383Methods for enhancing the specific uptake of botulinum neurotoxins into cells
#384Benzimidazole-carboxamide compounds as 5-HTreceptor agonists
#385MECHANISM AND DRUG TARGETS FOR REDUCING CELL EDEMA (NEUROPROTECTION) AND CYTOPLASMIC EXCITABILITY IN ASTROCYTES IN NORMAL AND PATHOLOGICAL STATES
#386IN VITRO METHODS OF IDENTIFYING MODULATORS OF NEUROMUSCULAR JUNCTION ACTIVITY
#387DIRECTED DIFFERENTIATION OF ASTROCYTES FROM HUMAN PLURIPOTENT STEM CELLS FOR USE IN DRUG SCREENING AND THE TREATMENT OF AMYOTROPHIC LATERIAL SCLEROSIS (ALS)
#388AGE-MODIFIED CELLS AND METHODS FOR MAKING AGE-MODIFIED CELLS
#389SCREENING METHOD USING INDUCED NEURONS
#390METHODS AND COMPOSITIONS FOR CHARACTERIZATION OF GLIOBLASTOMA MULTIFORME TUMORS AND CANCER STEM CELLS
#391METHODS OF IDENTIFYING, ISOLATING AND USING ODORANT AND AROMA RECEPTORS
#392ISOLATION OF HUMAN NEURAL STEM CELLS FROM AMNIOTIC FLUID OF PATIENTS WITH NEURAL TUBE DEFECTS
#393Methods for identifying arthropod repellents and attractants, and compounds and compositions identified by such methods
#394Methods for treating a brain tissue damage by cultured adult pluripotent olfactory stem cells
#395Culture medium for generating microglia from pluripotent stem cells and related methods
#396METHODS FOR TREATING NEURAL CELL SWELLING
#397TUNABLE NEURONAL NETWORK AND AN ARTIFICIAL EYE
#398TRIM11 for degradation of protein aggregates
#399COMPOSITIONS AND METHODS FOR NEURONAL DIFFERENTIATION OF CELLS
#400Methods and compositions for translational profiling and molecular phenotyping
#401Polynucleotides encoding anti-human receptor-type protein tyrosine phosphatase sigma antibodies
#402MODELING NEURAL NETWORK DYSFUNCTION
#403GENERATING INDUCED NEURAL PROGENITOR CELLS FROM BLOOD
#404SYNAPTIC VESICLE CYCLING ASSAYS AND SYSTEMS
#405Liquid injection method
#406Microfluidic Devices for Cells or Organ based Multimodal Activation and Monitoring system
#407Transgenic mouse model for dementia
#408ELECTRONIC NEURON PAIN ASSAY
#409OPTOGENETIC THERAPEUTIC AND METHOD OF TREATING RETINAL DEGENERATIVE AND NEURODEGENERATIVE DISEASES
#410METHOD FOR TREATING TAU PROTEIN-MEDIATED DEGENERATIVE NEURONAL DISEASE
#411METHODS FOR INDUCING NEUROGENESIS
#412Vitamin D receptor/SMAD genomic circuit gates fibrotic response
#413Blood brain barrier models and methods to generate and use the same
#414Methods for labeling and manipulating a cellular circuit
#415DIRECT CONVERSION OF CELLS TO CELLS OF OTHER LINEAGES
#416Methods for differentiating pluripotent cells
#417Light-activated chimeric opsins and methods of using the same
#418Method and system for imaging and analysis of a biological specimen
#419Apparatus for manufacturing display module
#420Nervous system-specific transmembrane proteasome complex that modulates neuronal signaling through extracellular signaling via brain activity peptides
#421Method of inhibiting microglial cell migration and treating traumatic brain injury
#422Indole and indoline derivatives and methods of use thereof
#423Use of P97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
#424Production of midbrain dopaminergic neurons and methods for the use thereof
#425Method for differentiation into retinal ganglion cells from stem cells
#426Method of differentiating human pluripotent stem cells into primitive macrophages
#427Screening method for pain suppressor and pharmaceutical composition for prevention or treatment of pain
#428BRAIN IN VITRO MODELS, DEVICES, SYSTEMS, AND METHODS OF USE THEREOF
#429DIRECT CONVERSION OF CELLS TO CELLS OF OTHER LINEAGES
#430PATTERNED NEUROMUSCULAR JUNCTIONS AND METHODS OF USE
#431Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNS
#432MUTANT NQ-RHODOPSIN KR 2
#433CHEMICAL MODEL OF A NEURODEGENERATIVE DISEASE, METHOD FOR PREPARATION AND USES OF SAME
#434Modulation and detection of a neuronal alternative splicing regulatory network for treatment and diagnosis of neurological disorders
#435Microfluidic device for three dimensional and compartmentalized coculture of neuronal and muscle cells, with functional force readout
#436Chiral Substituted Amyloid Beta Peptides
#437COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE
#438METHODS AND COMPOSITIONS FOR TREATING BRAIN DISEASES
#439Drug efficacy test method for dementias utilizing astrocyte-derived exosomes
#440Method of Identifying Transmembrane Protein-interacting Compounds
#441Neuronal Axon Mimetics For In Vitro Analysis Of Neurological Diseases, Myelination, And Drug Screening
#442Production method for retinal tissue
#443Methods for treating central or peripheral nervous system damage
#444Neuroprotective Chemicals and Methods for Identifying and Using Same
#445DOPAMINERGIC NEURONAL SURVIVAL-PROMOTING FACTORS AND USES THEREOF
#446SYSTEMS AND METHODS FOR ASSESSING INTER-CELL COMMUNICATION
#447Methods for identifying arthropod repellents and attractants, and compounds and compositions identified by such methods
#448Methods for identifying a receptor for a ligand and uses thereof
#449NEURAL MICROPHYSIOLOGICAL SYSTEMS AND METHODS OF USING THE SAME
#450Methods to treat neurodegenerative diseases
#451NMDA RECEPTOR ANTAGONISTS FOR TREATING GAUCHER DISEASE
#452MODEL SYSTEMS FOR SCREENING MODULATORS OF mTOR SIGNALING
#453DERIVATION OF NEURAL CREST STEM CELLS AND USES THEREOF
#454Methods of modifying neuronal function by changing intracellular magnesium levels
#455EVALUATION OF THE POTENTIAL RISK OF DRUG INDUCED MOOD DISTURBANCE AND SUICIDE: USE OF A DEDICATED PLATFORM
#456Microglia derived from pluripotent stem cells and methods of making and using the same
#457Biomaterials for neuronal implants and use of said biomaterials in the diagnosis and therapy of neuronal diseases
#458Microfluidic device for cell-based assays
#459COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS
#460In vitro blood-brain barrier model
#461High-throughput screening for compounds modulating expression of cellular macromolecules
#462Methods for diagnosing and treating Alzheimer's disease
#463miR-96-5p inhibitor and a screening method for the inhibitor
#464Treating myelin diseases with optimized cell preparations
#465Identification, diagnosis, and treatment of neuropathologies, neurotoxicities, tumors, and brain and spinal cord injuries using electrodes with microvoltammetry
#466Oligonucleotides for inducing paternal UBE3A expression
#467Method for preparation of retinal ganglion cells
#468Method and pharmaceutical composition for use in the treatment of neurodegenerative disorders
#469Cellular discovery platform for neurodegenerative diseases
#470Graphene and graphene-related materials for manipulation of cell membrane potential
#471Pharmaceutical composition for preventing or treating neurodegenerative diseases
#472Diagnostic methods for neural disorders
#473Pluripotent cell lines and methods of use thereof
#474In vitro model for neuronal death
#475REGULATORS OF ANAPLASTIC LYMPHOMA KINASE AND USES THEREOF
#476METHODS OF GENERATING CORNEAL CELLS AND CELL POPULATIONS COMPRISING SAME
#477Channelrhodopsins for optical control of cells
#478IDENTIFICATION OF COMPOUNDS THAT DISPERSE TDP-43 INCLUSIONS
#479Layerless bioprinting via dynamic optical projection and uses thereof
#480Benzimidazole-carboxamide compounds as 5-HTreceptor agonists
#481Methods of delivering a polypeptide molecule to Otx2 target cells using an Otx2 targeting peptide
#482Selective, directable electrotaxis of precursor cells with biphasic electrical stimulation
#483Adult oligodendrocyte-type 2 astrocyte progenitor cell production method
#484Modulation of synaptic maintenance
#485Gangliosides for standardizing and increasing the sensitivity of cells to botulinum neurotoxins in in vitro test systems
#486Composition for inducing direct transdifferentiation into oligodendrocyte progenitor cells from somatic cells and use thereof
#487NOCICEPTOR-LIKE CELLS DIFFERENTIATED FROM HUMAN NEURAL PROGENITORS AND USES THEREOF
#488Neuroprotective chemicals and methods for identifying and using same
#489High MAST2-affinity polypeptides and uses thereof
#490INDUCED PLURIPOTENT STEM CELL MODEL OF NOONAN SYNDROME AND USE THEREOF
#491METHOD FOR SCREENING THERAPEUTIC AND/OR PROPHYLACTIC AGENTS FOR ALZHEIMER'S DISEASE
#492TREATMENT OF NEURODEGENERATIVE AND NEURODEVELOPMENTAL DISEASES BY INHIBITION OF THE a2-Na/K ATPase/a-ADDUCIN COMPLEX
#493IN VITRO ASSAYS FOR INHIBITION OF MICROGLIAL ACTIVATION
#494CONVERSION OF NON-NEURONAL CELLS INTO NEURONS
#495Adeno-associated virus virions with variant capsid and methods of use thereof
#496Adeno-associated virus virions with variant capsid and methods of use thereof
#497Neurodegenerative disorders
#498TENEURIN C-TERMINAL ASSOCIATED PEPTIDES (TCAP) AND METHODS AND USES THEREOF
#499METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIES
#500SOLUBLE HIGH MOLECULAR WEIGHT (HMW) TAU SPECIES AND APPLICATIONS THEREOF
#501Modulation of synaptic maintenance
#502Compositions and methods for in vitro assays of fibrin activity
#503METHODS FOR PROMOTING MOTOR NEURON SURVIVAL
#504Modulation of Microglia Activation
#505DIAGNOSTIC METHODS FOR NEURAL DISORDERS
#506Systems and methods for assessing data collected from an electrically active cell culture
#507AGENTS DIRECTED AGAINST A CIS RGMA/NEOGENIN INTERACTION OR LIPID RAFTS AND USE OF THE SAME IN METHODS OF TREATMENT
#508Isolation of human neural stem cells from amniotic fluid of patients with neural tube defects
#509TREATMENT OF TINNITUS THROUGH MODULATION OF CHLORIDE CO-TRANSPORTER NKCC1 IN THE AUDITORY SYSTEM
#510Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perception
#511Method for assessment of neural function by establishing analysis module
#512GENOMIC ALTERATIONS ASSOCIATED WITH SCHIZOPHRENIA AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME
#513Method for preparation of induced dopaminergic progenitors using direct reprogramming
#514Methods for treating spinocerebellar ataxia type I using RPA1
#515Cells expressing apolipoprotein E and uses thereof
#516Nerve regenerating or nerve growth-promoting pharmaceutical composition containing Vax protein as active ingredient
#517Compositions and methods for modulating neuronal excitability and motor behavior
#518DIRECTED DIFFERENTIATION OF ASTROCYTES FROM HUMAN PLURIPOTENT STEM CELLS FOR USE IN DRUG SCREENING AND THE TREATMENT OF AMYOTROPHIC LATERIAL SCLEROSIS (ALS)
#519Light-activated chimeric opsins and methods of using the same
#520Method of treating glioma
#521Method of preparing induced neural stem cells reprogrammed from non-neuronal cells using HMGA2
#522Methods for the treatment of neurological disorders and diseases using FNDC5
#523MODULATORS OF IL-12 AND/OR IL-23 FOR THE PREVENTION OR TREATMENT OF ALZHEIMER'S DISEASE
#524Means and methods for the determination of the biological activity of neurotoxin polypeptides in cells
#525METHOD OF NOCICEPTOR DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS AND USES THEREOF
#526Treatment of mood and stress related disorders
#527METHOD OF REGULATING NEURONAL AXON ELONGATION
#528Treatment and prevention of stroke and other neurological disorders
#529Human pluripotent stem cell-based models for predictive developmental neural toxicity
#530Derivation of human microglia from pluripotent stem cells
#531Modulation of synaptic maintenance
#532Adeno-associated virus virions with variant capsid and methods of use thereof
#533Full head surrogate with live neurons for helmet testing and evaluation
#534Modulation of axon degeneration
#535METHOD AND MEDIUM FOR NEURAL DIFFERENTIATION OF PLURIPOTENT CELLS
#536Neuronal cells cultured on microparticles and methods of using same
#537Insect repellent and attractants
#538Fluorogenic pH sensitive dyes and their method of use
#539Mechanism and drug targets for reducing cell edema (neuroprotection) and cytoplasmic excitability in astrocytes in normal and pathological states
#540Screening methods for cognitive enhancers
#541IL-34 receptor assays and uses thereof
#542Method for measuring cell-to-cell transmission of α-synuclein aggregates using bimolecular fluorescence complementation system and method for screening a substance for preventing or treating neurodegenerative disease using the same
#543Neural networks formed from cells derived from pluripotent stem cells
#544Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells
#545Technologies, Methods, and Products of Small Molecule Directed Tissue and Organ Regeneration from Human Pluripotent Stem Cells
#546Age-modified cells and methods for making age-modified cells
#547Vitamin D receptor/SMAD genomic circuit gates fibrotic response
#548miR-96-5p INHIBITOR AND A SCREENING METHOD FOR THE INHIBITOR
#549Steroidal nitrones for the treatment and prevention of a cerebral stroke or ischaemia, alzheimer and parkinson disease and amyotrophic lateral sclerosis
#550Method for searching for malodor control agent, malodor control agent, and malodor control method
#551METHODS, COMPOSITIONS AND KITS FOR PROMOTING MOTOR NEURON SURVIVAL AND TREATING AND DIAGNOSING NEURODEGENERATIVE DISORDERS
#552MODEL OF ALZHEIMER'S DISEASE
#553Method and Medium for Amplifying Neural Precursor Cells
#554Devices and methods comprising neuromuscular junctions
#555CELLULAR DISCOVERY PLATFORM FOR NEURODEGENERATIVE DISEASES
#556Composition and method for preventing or treating a tauopathy
#557TREATING LYSOSOMAL STORAGE DISEASE
#558SCREENING METHOD FOR THERAPEUTIC AGENTS FOR CHARCOT-MARIE-TOOTH DISEASE AND SELF-DIFFERENTIATION MOTOR NEURONS USED THEREFOR
#559METHODS FOR IDENTIFYING ARTHROPOD REPELLENTS AND ATTRACTANTS, AND COMPOUNDS AND COMPOSITIONS IDENTIFIED BY SUCH METHODS
#560Light-activated chimeric opsins and methods of using the same
#561HIGH THROUGHPUT SCREENING OF AGENTS ON DOPAMINERGIC NEURONS
#562METHODS AND COMPOSITIONS FOR TREATING BRAIN DISEASES
#563METHOD FOR GENERATING RETINAL PIGMENT EPITHELIUM (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCs)
#564Modulation of synaptic maintenance
#565Modulation of synaptic maintenance
#566Modulation of synaptic maintenance
#567METHODS OF DETECTING NEUROTOXIN USING SYNAPTIC ACTIVITY
#568METHODS FOR TREATING NEURAL CELL SWELLING
#569Compositions and Methods for Parkinson's Disease Treatment by BDNF-flag Gene Transfer through Neurotensin Polyplex to Nigral Dopamine Neuro
#570Three dimensional heterogeneously differentiated tissue culture
#571Human glial chimeric model for drug candidate assessment in human gliotrophic viral infections and progressive multifocal encephalopathy
#572Chemical model of a neurodegenerative disease, method for preparation and uses of same
#573Micropillar arrays for assaying myelination
#574Megastokes amino-triazolyl-BODIPY compounds and applications to live neuron staining and human serum albumin FA1 drug site probing
#575MODELS FOR PARKINSON'S DISEASE STUDIES
#576Diagnostic methods for neural disorders
#577ANALYSIS OF COMPOUNDS FOR PAIN AND SENSORY DISORDERS
#578Fluorescent Chemical Dye for Visualization of Neural Stem Cell Symmetric and Asymmetric Division
#579Methods for identifying candidates for the treatment of neurodegenerative diseases
#580Direct conversion of cells to cells of other lineages
#581Cellular test systems for the determination of the biological activities of neurotoxin polypeptides
#582Double caged GABA compounds, bis-CNB-GABA
#583Production of midbrain dopaminergic neurons and methods for the use thereof
#584Methods of reducing TDP-43-mediated neuronal cytotoxicity in amyotrophic lateral sclerosis by a UPF1 polypeptide or polynucleotide
#585METHODS OF IDENTIFYING COMPOUNDS FOR TREATING DEPRESSION AND OTHER RELATED DISEASES
#586Treatment for neurodegeneration
#587Adeno-associated virus virions with variant capsid and methods of use thereof
#588Adeno-associated virus virions with variant capsid and methods of use thereof
#589Method of promoting excitatory synapse formation with an anti-Ephexin5 phospho-Y361 antibody
#590Chinese herbal aqueous extract having anti-anxiety activities and method of in vitro evaluating the same
#591Methods to treat neurodegenerative diseases
#592Benzimidazole-carboxamide compounds as 5-HTreceptor agonists
#593Immortalization of cells including neuronal cells
#594Use of nicotinamide riboside to treat hearing loss
#595Retinal pigment epithelial primary cell culture system producing subcellular deposits
#596Microfluidic device for generating neural cells to simulate post-stroke conditions
#597Fluorescent protein voltage sensors for measuring membrane potential and imaging high-frequency neuronal electrical activity
#598Treatment of Neurodegeneration and Neuroinflammation
#599DRUG SCREENING PLATFORM FOR RETT SYNDROME
#600Method for in vitro differentiation of blood circulating cells into neuronal-like cells and applications thereof